Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

High-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1-infected women.

Papasavvas E, Surrey LF, Glencross DK, Azzoni L, Joseph J, Omar T, Feldman MD, Williamson AL, Siminya M, Swarts A, Yin X, Liu Q, Firnhaber C, Montaner LJ.

Oncoimmunology. 2016 Jan 19;5(5):e1128612. doi: 10.1080/2162402X.2015.1128612. eCollection 2016 May.

PMID:
27467943
2.

Nelfinavir is effective against human cervical cancer cells in vivo: a potential treatment modality in resource-limited settings.

Davis MA, Delaney JR, Patel CB, Storgard R, Stupack DG.

Drug Des Devel Ther. 2016 Jun 2;10:1837-46. doi: 10.2147/DDDT.S102241. eCollection 2016.

3.

Effect of Low CD4 Cell Count on Cervical Squamous Intraepithelial Lesions among HIV-Positive Women in Enugu, Southeastern Nigeria.

Enebe JT, Dim CC, Nnakenyi EF, Ezegwui HU, Ozumba BC.

J Clin Diagn Res. 2015 Nov;9(11):QC07-10. doi: 10.7860/JCDR/2015/14808.6785. Epub 2015 Nov 1.

4.

Oral Lopinavir Use and Human Papillomavirus Infection in HIV-Positive Women.

Lahiri CD, Dugan KB, Xie X, Reimers L, Burk RD, Anastos K, Massad LS, Eltoum IE, Xue X, DʼSouza G, Flowers L, Palefsky JM, Rahangdale L, Strickler HD, Ofotokun I.

J Acquir Immune Defic Syndr. 2015 Oct 1;70(2):e63-6. doi: 10.1097/QAI.0000000000000752. No abstract available.

PMID:
26181819
5.

A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil.

Castilho JL, Levi JE, Luz PM, Cambou MC, Vanni T, de Andrade A, Derrico M, Veloso VG, Grinsztejn B, Friedman RK.

BMC Cancer. 2015 Jun 23;15:478. doi: 10.1186/s12885-015-1486-4.

6.

Effect of highly active antiretroviral therapy (HAART) and menopause on risk of progression of cervical dysplasia in human immune-deficiency virus- (HIV-) infected women.

Kim SC, Messing S, Shah K, Luque AE.

Infect Dis Obstet Gynecol. 2013;2013:784718. doi: 10.1155/2013/784718. Epub 2013 Dec 18.

7.

Risk Factors for the presence of anal intraepithelial neoplasia in HIV+ men who have sex with men.

Richel O, De Vries HJ, Dijkgraaf MG, Van Noesel CJ, Prins JM.

PLoS One. 2013 Dec 18;8(12):e84030. doi: 10.1371/journal.pone.0084030. eCollection 2013.

8.

Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States.

Robbins HA, Shiels MS, Pfeiffer RM, Engels EA.

AIDS. 2014 Mar 27;28(6):881-90. doi: 10.1097/QAD.0000000000000163.

9.

Highly active antiretroviral therapy and cervical dysplasia in HIV-positive women in South Africa.

Firnhaber C, Westreich D, Schulze D, Williams S, Siminya M, Michelow P, Levin S, Faesen M, Smith JS.

J Int AIDS Soc. 2012 Jun 7;15(2):17382. doi: 10.7448/IAS.15.2.17382.

10.

Increased regression and decreased incidence of human papillomavirus-related cervical lesions among HIV-infected women on HAART.

Adler DH, Kakinami L, Modisenyane T, Tshabangu N, Mohapi L, De Bruyn G, Martinson NA, Omar T.

AIDS. 2012 Aug 24;26(13):1645-52.

11.

Prevalence and risk factors for cervical squamous intraepithelial lesions among women infected with HIV-1 in Makurdi, Nigeria.

Swende TZ, Ngwan SD, Swende LT.

Int J Womens Health. 2012;4:55-60. doi: 10.2147/IJWH.S21205. Epub 2012 Feb 14.

12.
13.

Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana.

Ramogola-Masire D, McGrath CM, Barnhart KT, Friedman HM, Zetola NM.

Int J Gynecol Pathol. 2011 Nov;30(6):591-6. doi: 10.1097/PGP.0b013e31821bf2a6.

14.

HIV-associated anal cancer.

Newsom-Davis T, Bower M.

F1000 Med Rep. 2010 Dec 8;2:85. doi: 10.3410/M2-85.

15.

Effect of stress and depression on the frequency of squamous intraepithelial lesions.

Massad LS, Agniel D, Minkoff H, Watts DH, D'Souza G, Levine AM, Darragh TM, Young M, Cajigas A, Weber K.

J Low Genit Tract Dis. 2011 Jan;15(1):42-7. doi: 10.1097/LGT.0b013e3181e66a82.

16.

Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort.

Omar T, Schwartz S, Hanrahan C, Modisenyane T, Tshabangu N, Golub JE, McIntyre JA, Gray GE, Mohapi L, Martinson NA.

AIDS. 2011 Jan 2;25(1):87-94. doi: 10.1097/QAD.0b013e328340fd99.

17.

The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents.

Shrestha S, Sudenga SL, Smith JS, Bachmann LH, Wilson CM, Kempf MC.

BMC Infect Dis. 2010 Oct 14;10:295. doi: 10.1186/1471-2334-10-295.

18.

The impact of HAART on HPV-related cervical disease.

Adler DH.

Curr HIV Res. 2010 Oct;8(7):493-7. Review.

19.

Outcomes after an excisional procedure for cervical intraepithelial neoplasia in HIV-infected women.

Reimers LL, Sotardi S, Daniel D, Chiu LG, Van Arsdale A, Wieland DL, Leider JM, Xue X, Strickler HD, Garry DJ, Goldberg GL, Einstein MH.

Gynecol Oncol. 2010 Oct;119(1):92-7. doi: 10.1016/j.ygyno.2010.06.012.

20.
Items per page

Supplemental Content

Write to the Help Desk